Good news for the FDA...hope the meantime Leavitt releases information so he is not held held in contempt relative to the information regarding the antibiotic Ketek and the serious side effects in the report...BD 

FDA on Monday named Janet Woodcock, deputy commissioner and chief medical officer at the agency, as director of the Center for Drug Evaluation and Research, which reviews new medications for safety and effectiveness, USA Today reports. Woodcock has served as acting director of CDER since October 2007, according to FDA spokesperson Heidi Rebello (USA Today, 3/11). She will relinquish her current two positions, an FDA spokesperson said.
As director of CDER, Woodcock will oversee the implementation of a 2007 law that requires FDA to hire hundreds of new staffers and develop procedures to implement increased authority over medications after they reach the market. Woodcock previously served as director of CDER from 1994 to 2005.

FDA Names Woodcock As Permanent Director Of CDER; Leavitt Releases Documents To Avoid Contempt Charges


Post a Comment